Abstract
The prevalence of viral hepatitis markers in apparently healthy individuals of both sexes, born and living in both urban and rural areas of all the Portuguese provinces, was studied by radioimmunoassay.
The anti-HAV prevalence was determined in 1770 individuals, 1-84 years old, divided into 8 age groups. The HBsAg prevalence was determined in 1440 individuals, 15-84 years old, divided into 5 age groups, while the anti-HBs prevalence was determined in 1980 individuals, 1-84 years old, divided into 8 age groups. The data were standardized for the Portuguese population.
The anti-HAV results were similar for both sexes and showed a general prevalence of 84.9%. No significant difference in the prevalences between urban and rural areas was found. Age-group prevalences of anti-HAV were: 1-4 years, 23.9%; 5-9 years, 61.3%; 10-14 years, 76.4%; 15-19 years, 93.4%; and over 30 years, 99%.
The HBsAg results showed a general prevalence of 1.25% for persons over 15 years old (2.04% for males and 0.78% for females). The anti-HBs results were similar for both sexes and showed a general prevalence of 24.3%. The northern provinces tended to have a higher anti-HBs prevalence than the southern ones, except for Lisbon province which had the highest figure. Age-group prevalences of anti-HBs were: 1-4 years, 7.6%; 5-9 years, 12.6%; 10-14 years, 8.7%; 15-19 years, 23.5%; 20-29 years, 28.4%; and over 30 years, between 30.0% and 34.3%.
Only 5.3% of the anti-HAV-positive individuals, 11.2% of the HBsAg carriers, and 9.2% of the anti-HBs-positive individuals had a history of acute hepatitis.
These results show that Portugal may be considered an endemic area for viral hepatitis infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dienstag J. L., Szmuness W., Stevens C. E., Purcell R. H. Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis. 1978 Mar;137(3):328–340. doi: 10.1093/infdis/137.3.328. [DOI] [PubMed] [Google Scholar]
- Frösner G. G., Papaevangelou G., Bütler R., Iwarson S., Lindholm A., Couroucé-Pauty A., Haas H., Deinhardt F. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol. 1979 Jul;110(1):63–69. doi: 10.1093/oxfordjournals.aje.a112788. [DOI] [PubMed] [Google Scholar]
- Iwarson S., Frösner G., Lindholm A., Norkrans G. The changed epidemiology of hepatitis A infection in Scandinavia. Scand J Infect Dis. 1978;10(2):155–156. doi: 10.3109/inf.1978.10.issue-2.12. [DOI] [PubMed] [Google Scholar]
- Papaevangelou G. J., Gourgouli-Fotiou K. P., Vissoulis H. G. Epidemiologic characteristics of hepatitis A virus infections in Greece. Am J Epidemiol. 1980 Oct;112(4):482–486. doi: 10.1093/oxfordjournals.aje.a113017. [DOI] [PubMed] [Google Scholar]
- Shikata T., Karasawa T., Abe K., Uzawa T., Suzuki H., Oda T., Imai M., Mayumi M., Moritsugu Y. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis. 1977 Oct;136(4):571–576. doi: 10.1093/infdis/136.4.571. [DOI] [PubMed] [Google Scholar]
- Sobeslavský O. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study. Bull World Health Organ. 1980;58(4):621–628. [PMC free article] [PubMed] [Google Scholar]
- Szmuness W. Recent advances in the study of the epidemiology of hepatitis B. Am J Pathol. 1975 Dec;81(3):629–650. [PMC free article] [PubMed] [Google Scholar]
- Wewalka F., Hadziyannis S., Pesendorfer F. X., Dragosics B., Base W. OMGE--Study on prevalence of hepatitis B surface antigen in different liver diseases. Scand J Gastroenterol Suppl. 1979;56:55–68. [PubMed] [Google Scholar]
- Zuckerman A. J. The three type of human viral hepatitis. Bull World Health Organ. 1978;56(1):1–20. [PMC free article] [PubMed] [Google Scholar]